Wimmer Associates 1’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Sell |
5,592
-2
| -0% | -$890 | 1.27% | 20 |
|
|
2025
Q1 | $2.42M | Sell |
5,594
-11
| -0.2% | -$4.75K | 1.27% | 20 |
|
|
2024
Q4 | $2.26M | Sell |
5,605
-6
| -0.1% | -$2.42K | 1.12% | 27 |
|
|
2024
Q3 | $2.61M | Buy |
5,611
+15
| +0.3% | +$6.98K | 1.28% | 23 |
|
|
2024
Q2 | $2.62M | Buy |
5,596
+119
| +2% | +$55.8K | 1.34% | 20 |
|
|
2024
Q1 | $2.29M | Buy |
5,477
+86
| +2% | +$35.9K | 1.2% | 25 |
|
|
2023
Q4 | $2.19M | Buy |
5,391
+370
| +7% | +$151K | 1.24% | 26 |
|
|
2023
Q3 | $1.75M | Buy |
5,021
+473
| +10% | +$164K | 1.09% | 29 |
|
|
2023
Q2 | $1.6M | Buy |
4,548
+2,335
| +106% | +$822K | 0.96% | 31 |
|
|
2023
Q1 | $772K | Buy |
2,213
+69
| +3% | +$24.1K | 0.49% | 53 |
|
|
2022
Q4 | $619K | Hold |
2,144
| – | – | 0.41% | 65 |
|
|
2022
Q3 | $669K | Buy |
2,144
+61
| +3% | +$19K | 0.44% | 59 |
|
|
2022
Q2 | $587K | Buy |
2,083
+1,299
| +166% | +$366K | 0.38% | 64 |
|
|
2022
Q1 | $205K | Buy |
+784
| New | +$205K | 0.11% | 117 |
|